Related Experiment Video

Updated: Jul 17, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

[Flt-3/ITD mutation in pediatric leukemia and its clinical significance]

Jie Wang1, Tong Wang, Shu Li

  • 1Department of Biochemistry and Molecular Biology, Shenyang Medical College, Shenyang, Liaoning, 110034, P. R. China. wangjie19932002@163.com

AI Zheng = Aizheng = Chinese Journal of Cancer
|January 16, 2007
PubMed
Abstract

Insights

Flt-3 internal tandem duplication (Flt-3/ITD) mutations are common in pediatric acute myeloid leukemia (AML) but rare in acute lymphoblastic leukemia (ALL). Flt-3/ITD is a significant marker for AML prognosis.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Context:

  • Flt-3 internal tandem duplication (Flt-3/ITD) is a frequent mutation in acute myeloid leukemia (AML) and impacts prognosis.
  • Pediatric leukemia encompasses various subtypes, including AML and acute lymphoblastic leukemia (ALL).

Purpose:

  • To investigate the prevalence of Flt-3/ITD mutations in pediatric leukemia.
  • To analyze the clinical significance and prognostic value of Flt-3/ITD mutations in pediatric leukemia.

Summary:

  • Flt-3/ITD mutations were detected in 17.21% of pediatric AML cases and 1.61% of pediatric ALL cases.
  • No Flt-3/ITD mutations were found in juvenile chronic myelogenous leukemia (JCML) or myelodysplastic syndromes (MDS).
  • Flt-3/ITD mutations were associated with a significantly shorter median survival time in AML patients.

Impact:

  • Flt-3/ITD mutations are strongly correlated with the onset and progression of pediatric AML.
  • Flt-3/ITD serves as a crucial prognostic marker for pediatric AML, aiding in risk stratification and treatment decisions.

More Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life